Earlybird Global committed to building a new Ukraine
Vinnytsia attracting foreign investments
Ukrainian City of Vinnytsia Welcomes International Partners to Modernize its Infrastructure, and Partners With Earlybird Global and SRDB Law Firm, to attract international partners on three strategic projects:
Water and Wastewater Facilities,
Transportation System,
Energy independence and security.
Earlybird Global member of
U.S.-Ukraine Business Council
On the road to rebuilding Ukraine
The U.S.-Ukraine Business Council was established in October 1995 to advance U.S. companies' trade and investment interests in Ukraine's significant emerging market, advocate for measures to improve conditions for bilateral trade and investment, and generally promote strong, friendly bilateral ties.
Investment memorandum with the city of Ternopil
Energy independance and modernization of utilities
On July 10, 2024, the city of Ternopil, represented by Mayor Serhiy Nadal, has signed an investment memorandum with Earlybird Global and SRDB Law Firm, both represented by Nabil Sioufi, designed to attract international investors on three strategic projects: 1. Combined Heating and Power (CHP) plant 2. Water and Wastewater Treatment Facilities. 3. Urban Solar Energy.
Attracting investments in Nizhyn
Energy security, Industrial parks, Water.
EarlyBird Global cooperates with the city of Nizhyn and its Mayor Oleksandr Kodola to attract investments into key sectors of the local economy, such as energy security, industrial parks, and water treatment.
Biotech R&D on Le Figaro TV
A revolution in bacterial anti-proliferation
Showcasing a partnership in health technology between a biotech company and a major Public Research institution (CNRS National Center for Scientific Research): a lead into a revolution in bacterial anti-proliferation in public spaces.
Biotech R&D on BFM TV
A new therapy for MASH disease
Showcasing a partnership in drug discovery between a biotech company and a major Public Research institution (INSERM National Institute for Health and Medical Research): a lead into a new therapy for MASH disease (Metabolic Dysfunction-Associated Steatohepatitis)
©2024 Copyright. All rights reserved.
We need your consent to load the translations
We use a third-party service to translate the website content that may collect data about your activity. Please review the details in the privacy policy and accept the service to view the translations.